Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain. 22 Sep Continue reading →
Biochemical and immunohistochemical changes in delta-9-tetrahydrocannabinol-treated type 2 diabetic rats. 22 Sep Continue reading →
Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study. 21 Sep Continue reading →
Antidiabetic effects of sub-chronic administration of the cannabinoid receptor (CB1) antagonist, AM251, in obese diabetic (ob/ob) mice. Continue reading →
Cannabidiol protects retinal neurons by preserving glutamine synthetase activity in diabetes. 02 Jun Continue reading →
Hyperglycemia induces apoptosis via CB1 activation through the decrease of FAAH 1 in retinal pigment epithelial cells. 02 Jun Continue reading →
Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. 02 Jun Continue reading →
Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes. 02 Jun Continue reading →